stella
beta
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases — Stella
Recruiting
Back to Leptomeningeal Metastasis trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
The Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas
View full record on ClinicalTrials.gov